NM-IL-12 (rHuIL-12) In Relapsed/Refractory Diffuse Large B- Cell Lymphoma (DLBCL) Undergoing Salvage Chemotherapy

Clinical trial NCT02544724 · UNKNOWN

Trial details

NCT number: NCT02544724
Sponsor: Neumedicines Inc.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphoma, Large B-Cell, Diffuse (DLBCL)

Start date: 2016-11-01
Primary completion: 2017-08-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.